Literature DB >> 20004089

Plasma ammonia response to incremental cycling and walking tests in COPD.

L D Calvert1, M C Steiner, M D Morgan, S J Singh.   

Abstract

OBJECTIVE: It is well documented that plasma ammonia accumulates during exercise under conditions of metabolic stress. Metabolic stress (when skeletal muscle ATP supply fails to meet demand) occurs at low work rates during cycling in patients with COPD, but not been described during walking. Walking is an important activity for many patients with COPD and is commonly prescribed in pragmatic outpatient pulmonary rehabilitation programmes. In this study we explored whether metabolic stress occurs during incremental walking at the low work rates these patients achieve.
METHODS: Twenty-nine subjects with stable COPD [mean(SD) age 68(7)years, FEV(1) 50(19)% predicted] performed maximal cardiopulmonary exercise tests on a cycle ergometer and treadmill. Plasma ammonia concentration was measured at rest, 1 and 2min of exercise, peak exercise and 2min recovery.
RESULTS: Subjects achieved mean(SD) cycle work rate of 57(20)W with VO(2max) 15.5(4.6)ml/min per kg, and treadmill distance 284(175)m with VO(2peak) 16.8(4.2)ml/min per kg. Plasma ammonia concentration rose significantly (p<0.001) with walking [mean(SEM) change 24.7(3.8)micromol/l] and cycling [mean(SEM) change 35.2(4.3)micromol/l], but peak exercise ammonia was lower in walking (p<0.01). In a subgroup of subjects (n=7) plasma ammonia did not rise during either cycling or walking despite similar lactate rise and peak exercise indices.
CONCLUSION: Our data indicate that failure of muscle ATP re-synthesis to meet demand and development of metabolic stress can occur during walking in COPD patients at the low work rates these patients achieve. This may therefore be a factor contributing to exercise limitation independent of ventilatory limitation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004089     DOI: 10.1016/j.rmed.2009.11.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

1.  The effect of hyperammonemia on myostatin and myogenic regulatory factor gene expression in broiler embryos.

Authors:  R A Stern; C M Ashwell; S Dasarathy; P E Mozdziak
Journal:  Animal       Date:  2015-02-18       Impact factor: 3.240

Review 2.  Ammonia toxicity: from head to toe?

Authors:  Srinivasan Dasarathy; Rajeshwar P Mookerjee; Veronika Rackayova; Vinita Rangroo Thrane; Balasubramaniyan Vairappan; Peter Ott; Christopher F Rose
Journal:  Metab Brain Dis       Date:  2016-12-24       Impact factor: 3.584

Review 3.  Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective.

Authors:  Karin J C Sanders; Anita E M Kneppers; Coby van de Bool; Ramon C J Langen; Annemie M W J Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-09-07       Impact factor: 12.910

4.  The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD.

Authors:  Khaled Al-Shair; Umme Kolsum; Dave Singh; Jørgen Vestbo
Journal:  Lung       Date:  2016-08-22       Impact factor: 2.584

Review 5.  Wet, volatile, and dry biomarkers of exercise-induced muscle fatigue.

Authors:  Josef Finsterer; Vivian E Drory
Journal:  BMC Musculoskelet Disord       Date:  2016-01-21       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.